InvestLog
HYPD Hyperion DeFi, Inc. logo

HYPD Hyperion DeFi, Inc.

Healthcare
$3.62-7.18%ClosedMarket Cap: $18.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.66

P/S

17.32

EV/EBITDA

-1.76

DCF Value

$-1.61

FCF Yield

-420.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

63.7%

Operating Margin

-2012.6%

Net Margin

-3163.0%

ROE

-63.5%

ROA

-47.1%

ROIC

-31.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$244.3K$8.8M$—
Q4 null$496.2K$-39.8M$—
FY null$813.5K$-45.3M$—
Q3 null$302.5K$6.6M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$5.88

Target (Median)

$5.88

Target Range

$4.00 - $7.75

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Chardan CapitalBuy
2026-03-27

Trading Activity

Insider Trades

View All
Knox David R.officer: Chief Financial Officer
SellWed Apr 01
Rubenstein Robertofficer: General Counsel
SellMon Jan 12
Rubenstein Robertofficer
SellMon Jan 12
Knox David R.officer: Chief Financial Officer
BuyMon Jan 05
Strahlman Ellen Rdirector
BuyTue Dec 30

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

—

Beta

2.58

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.

Peers

BTAI logoBTAIECOR logoECORJSPR logoJSPRMODD logoMODDMURA logoMURAMYO logoMYONMTC logoNMTCPIII logoPIIIRBOT logoRBOTVRCA logoVRCA